Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease

Kaposi sarcoma (KS) herpesvirus–associated multicentric Castleman disease (KSHV-MCD) is a lymphoproliferative disorder, most commonly seen in HIV-infected patients, that has a high mortality if untreated. Concurrent KS is common. Although rituximab has reported activity in KSHV-MCD, its use is often...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Blood
Main Authors: Uldrick, Thomas S., Polizzotto, Mark N., Aleman, Karen, Wyvill, Kathleen M., Marshall, Vickie, Whitby, Denise, Wang, Victoria, Pittaluga, Stefania, O’Mahony, Deirdre, Steinberg, Seth M., Little, Richard F., Yarchoan, Robert
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2014
Teme:
Clinical Trials and Observations
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4256906/
https://ncbi.nlm.nih.gov/pubmed/25331113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-07-586800
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki